Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biorestorative Therapies Inc (BRTX)

Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,657
  • Shares Outstanding, K 6,920
  • Annual Sales, $ 150 K
  • Annual Income, $ -14,420 K
  • EBIT $ -13 M
  • EBITDA $ -13 M
  • 60-Month Beta 63.40
  • Price/Sales 77.73
  • Price/Cash Flow N/A
  • Price/Book 1.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.37
  • Number of Estimates 1
  • High Estimate -0.37
  • Low Estimate -0.37
  • Prior Year -0.57
  • Growth Rate Est. (year over year) +35.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3500 +14.07%
on 11/04/24
1.8000 -14.44%
on 11/04/24
-0.1100 (-6.67%)
since 10/11/24
3-Month
1.3201 +16.66%
on 08/14/24
1.9200 -19.79%
on 09/20/24
+0.1300 (+9.22%)
since 08/13/24
52-Week
1.0300 +49.51%
on 06/10/24
3.6699 -58.04%
on 02/05/24
-0.2386 (-13.42%)
since 11/13/23

Most Recent Stories

More News
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

BRTX : 1.5400 (-6.10%)
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

BRTX : 1.5400 (-6.10%)
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium

BRTX : 1.5400 (-6.10%)
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health

BRTX : 1.5400 (-6.10%)
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program

BRTX : 1.5400 (-6.10%)
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events

BRTX : 1.5400 (-6.10%)
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

BRTX : 1.5400 (-6.10%)
BioRestorative Therapies to Present in The Jan 26th Virtual Investor Summit Microcap Event

Melville, New York--(Newsfile Corp. - January 17, 2023) - BioRestorative Therapies (NASDAQ: BRTX) ("BioRestorative", "BRTX" or the "Company"), a clinical stage company focused on stem cell-based therapies,...

BRTX : 1.5400 (-6.10%)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027

EQNX::TICKER_START (OTCQB:OCEL),(NASDAQ:BRTX),(NASDAQ:MDXG),(NYSE:NNVC),(NASDAQ:VCEL) EQNX::TICKER_END

VCEL : 55.47 (-0.75%)
OCEL : 2.7500 (unch)
BRTX : 1.5400 (-6.10%)
MDXG : 7.47 (+0.13%)
NNVC : 1.3500 (unch)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027

/PRNewswire/ -- Chronic obstructive pulmonary disease is a chronic lung disease that prevents airflow from the lungs. The rising incidence of COPD is one...

OCEL : 2.7500 (unch)
BRTX : 1.5400 (-6.10%)
MDXG : 7.47 (+0.13%)
NNVC : 1.3500 (unch)
VCEL : 55.47 (-0.75%)

Business Summary

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM)...

See More

Key Turning Points

3rd Resistance Point 2.0733
2nd Resistance Point 1.9267
1st Resistance Point 1.7333
Last Price 1.5400
1st Support Level 1.3933
2nd Support Level 1.2467
3rd Support Level 1.0533

See More

52-Week High 3.6699
Fibonacci 61.8% 2.6615
Fibonacci 50% 2.3499
Fibonacci 38.2% 2.0384
Last Price 1.5400
52-Week Low 1.0300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar